Data as of Sep 19
| -0.06 / -5.22%|
The 2 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +450.46% increase from the last price of 1.09.
The current consensus among 1 polled investment analysts is to Buy stock in Opexa Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.